BTK Inhibitor Effective in RA
]]>(MedPage Today) -- An orally available inhibitor of Bruton's tyrosine kinase, an important regulator of B cell proliferation and myeloid cell activity, was modestly effective for treating rheumatoid arthritis and apparently safe in a phase II trial...
Read more »